Natac signs deal with IFFE Biotech

Natac to be a minority shareholder, providing our expertise for the production of Omega 3. 

Natac and IFFE FUTURA have agreed that Natac Group is to become a 20% shareholder of IFFE BIOTECH.

Natac will contribute worldwide and exclusive indefinite license to their intellectual property relating to the low phytanic acid production of Omega 3. Natac will provide all their patents relating to this intellectual property within the next 30 months.

IFFE Biotech will sign an additional service provision contract which will see Natac provide consultation on its technological development and plant related assistance for future operations plus assistance marketing the company’s products.

This website is not aimed at consumers.

The information is accessible in several countries and can include statements or product classifications not applicable in your country. The claims mentioned refer only to ingredients and, therefore, do not refer to finished products.